<--- Back to Details
First PageDocument Content
PDE5 inhibitors / Pfizer / Piperazines / Pyrazolopyrimidines / Sildenafil / Pulmonary hypertension / Clinical trial / Tadalafil / Riociguat / Chemistry / Organic chemistry / Lactams
Date: 2014-02-19 00:52:36
PDE5 inhibitors
Pfizer
Piperazines
Pyrazolopyrimidines
Sildenafil
Pulmonary hypertension
Clinical trial
Tadalafil
Riociguat
Chemistry
Organic chemistry
Lactams

tz-trcT-zzLL 15r3? + a52DEPT OF HEALTH

Add to Reading List

Source URL: www.hkam.org.hk

Download Document from Source Website

File Size: 544,17 KB

Share Document on Facebook

Similar Documents

Chemistry / Organic chemistry / GABAA receptor positive allosteric modulators / Alcohols / Prostaglandins / Treprostinil / Sodium channel blockers / Lorazepam / Niacin / Riociguat / Gemigliptin

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ORENITRAM® safely and effectively. See Full Prescribing Information for ORENITRAM. --------------------- DOSAGE FO

DocID: 1rcHl - View Document

Chemistry / Organic chemistry / PDE5 inhibitors / Lactams / Pyrimidines / Alcohols / Drugs / Avanafil / Tadalafil / Sildenafil / Menarini / Riociguat

Package leaflet: Information for the patient Spedra 50 mg tablets Spedra 100 mg tablets Spedra 200 mg tablets Avanafil This medicine is subject to additional monitoring. This will allow quick identification of new

DocID: 1qwp7 - View Document

Pyrimidines / Orphan drugs / Hypertension / Sulfonamides / Heart diseases / Pulmonary hypertension / Riociguat / Pulmonary artery pressure / Bosentan / Organic chemistry / Chemistry / Medicine

Clinical Commissioning Policy: National policy for targeted therapies for the treatment of pulmonary hypertension in adults Reference: NHS England – A11/P/c

DocID: 10t7Z - View Document

Morphinans / Ketones / Alcohols / Euphoriants / Organofluorides / Oxycodone / Quality use of medicines / Riociguat / Placebo / Chemistry / Medicine / Organic chemistry

DRUG NAME, FORM(S), STRENGTH(S), SPONSOR, TYPE OF SUBMISSION DRUG TYPE AND USE LISTING REQUESTED BY SPONSOR / PURPOSE OF SUBMISSION PBAC OUTCOME

DocID: X240 - View Document

PDE5 inhibitors / Pfizer / Piperazines / Pyrazolopyrimidines / Sildenafil / Pulmonary hypertension / Clinical trial / Tadalafil / Riociguat / Chemistry / Organic chemistry / Lactams

tz-trcT-zzLL 15r3? + a52DEPT OF HEALTH

DocID: VUVh - View Document